| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 993 | 21 | 1096 | 99 | 1205 | 206 | 1254 |
| ERLYTX | 94 | 0 | 0 | 3 | 37 | 10 | 61 |
| GI | 194 | 2 | 104 | 13 | 158 | 29 | 177 |
| GU | 439 | 5 | 261 | 32 | 390 | 70 | 426 |
| LEUK | 140 | 1 | 52 | 11 | 134 | 24 | 146 |
| LUNG | 202 | 2 | 104 | 14 | 170 | 30 | 183 |
| LYMPH | 393 | 5 | 261 | 36 | 438 | 62 | 377 |
| MELAN | 284 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 164 | 3 | 157 | 5 | 61 | 15 | 91 |
| MULT | 20 | 1 | 52 | 5 | 61 | 14 | 85 |
| OTHER | 38 | 0 | 0 | 4 | 49 | 5 | 30 |
| PREV | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2968 | 40 | 2087 | 223 | 2715 | 466 | 2836 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 120 | 7 | 365 | 17 | 207 | 32 | 195 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 669 | 11 | 574 | 48 | 584 | 101 | 615 |
| LUNG | 301 | 7 | 365 | 33 | 402 | 64 | 390 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 37 | 1 | 52 | 5 | 61 | 11 | 67 |
| PEOLC | 127 | 5 | 261 | 20 | 244 | 37 | 225 |
| PREV | 215 | 6 | 313 | 21 | 256 | 43 | 262 |
| SURV | 19 | 0 | 0 | 4 | 49 | 8 | 49 |
| SXQOL | 577 | 6 | 313 | 48 | 584 | 99 | 603 |
| Total | 2076 | 43 | 2243 | 196 | 2387 | 396 | 2412 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 993 | 21 | 1096 | 99 | 1205 | 206 | 1254 |
| CCD | 120 | 7 | 365 | 17 | 207 | 32 | 195 |
| ERLYTX | 104 | 0 | 0 | 3 | 37 | 11 | 67 |
| GI | 194 | 2 | 104 | 13 | 158 | 29 | 177 |
| GU | 439 | 5 | 261 | 32 | 390 | 70 | 426 |
| LEUK | 809 | 12 | 626 | 59 | 718 | 125 | 761 |
| LUNG | 503 | 9 | 470 | 47 | 572 | 94 | 572 |
| LYMPH | 394 | 5 | 261 | 36 | 438 | 62 | 377 |
| MELAN | 284 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 164 | 3 | 157 | 5 | 61 | 15 | 91 |
| MULT | 20 | 1 | 52 | 5 | 61 | 14 | 85 |
| OTHER | 75 | 1 | 52 | 9 | 110 | 16 | 97 |
| PEOLC | 127 | 5 | 261 | 20 | 244 | 37 | 225 |
| PREV | 218 | 6 | 313 | 21 | 256 | 43 | 262 |
| SURV | 19 | 0 | 0 | 4 | 49 | 8 | 49 |
| SXQOL | 579 | 6 | 313 | 48 | 584 | 99 | 603 |
| Total | 5044 | 83 | 4331 | 419 | 5102 | 862 | 5247 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 608 | 10 | 522 | 58 | 706 | 131 | 797 |
| ERLYTX | 51 | 0 | 0 | 2 | 24 | 7 | 43 |
| GI | 142 | 1 | 52 | 10 | 122 | 22 | 134 |
| GU | 368 | 4 | 209 | 23 | 280 | 53 | 323 |
| LEUK | 86 | 1 | 52 | 8 | 97 | 14 | 85 |
| LUNG | 129 | 0 | 0 | 5 | 61 | 14 | 85 |
| LYMPH | 251 | 2 | 104 | 27 | 329 | 38 | 231 |
| MELAN | 179 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 104 | 3 | 157 | 4 | 49 | 8 | 49 |
| MULT | 8 | 1 | 52 | 2 | 24 | 5 | 30 |
| OTHER | 38 | 0 | 0 | 4 | 49 | 5 | 30 |
| PREV | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1971 | 22 | 1148 | 144 | 1753 | 298 | 1813 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 107 | 6 | 313 | 15 | 183 | 27 | 164 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 306 | 4 | 209 | 25 | 304 | 48 | 292 |
| LUNG | 185 | 5 | 261 | 20 | 244 | 42 | 256 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 36 | 0 | 0 | 4 | 49 | 10 | 61 |
| PEOLC | 91 | 5 | 261 | 16 | 195 | 30 | 183 |
| PREV | 212 | 3 | 157 | 18 | 219 | 40 | 244 |
| SURV | 19 | 0 | 0 | 4 | 49 | 8 | 49 |
| SXQOL | 391 | 5 | 261 | 32 | 390 | 62 | 377 |
| Total | 1358 | 28 | 1462 | 134 | 1633 | 268 | 1632 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 791 | 12 | 626 | 69 | 840 | 159 | 968 |
| CCD | 136 | 4 | 209 | 15 | 183 | 35 | 213 |
| ERLYTX | 61 | 0 | 0 | 2 | 24 | 8 | 49 |
| GI | 147 | 0 | 0 | 10 | 122 | 24 | 146 |
| GU | 391 | 6 | 313 | 28 | 341 | 59 | 359 |
| LEUK | 392 | 5 | 261 | 33 | 402 | 62 | 377 |
| LUNG | 315 | 5 | 261 | 25 | 304 | 56 | 341 |
| LYMPH | 252 | 2 | 104 | 27 | 329 | 38 | 231 |
| MELAN | 179 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 101 | 3 | 157 | 4 | 49 | 8 | 49 |
| MULT | 22 | 1 | 52 | 3 | 37 | 7 | 43 |
| OTHER | 249 | 1 | 52 | 17 | 207 | 42 | 256 |
| PEOLC | 96 | 4 | 209 | 15 | 183 | 29 | 177 |
| PREV | 215 | 3 | 157 | 18 | 219 | 40 | 244 |
| SURV | 19 | 0 | 0 | 4 | 49 | 8 | 49 |
| SXQOL | 393 | 5 | 261 | 32 | 390 | 62 | 377 |
| Total | 3761 | 51 | 2662 | 303 | 3691 | 638 | 3885 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 841 | 15 | 783 | 78 | 950 | 163 | 992 |
| ERLYTX | 90 | 0 | 0 | 3 | 37 | 9 | 55 |
| GI | 110 | 1 | 52 | 8 | 97 | 18 | 110 |
| GU | 250 | 4 | 209 | 22 | 268 | 46 | 280 |
| LEUK | 108 | 0 | 0 | 8 | 97 | 19 | 116 |
| LUNG | 171 | 2 | 104 | 11 | 134 | 26 | 158 |
| LYMPH | 318 | 4 | 209 | 27 | 329 | 50 | 304 |
| MMYEL | 153 | 3 | 157 | 5 | 61 | 14 | 85 |
| MULT | 20 | 1 | 52 | 5 | 61 | 14 | 85 |
| Total | 2061 | 30 | 1566 | 167 | 2034 | 359 | 2185 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1958 | 31 | 1618 | 176 | 2143 | 348 | 2118 |
| AFFIL | 118 | 1 | 52 | 11 | 134 | 25 | 152 |
| CCOP/NCORP | 1253 | 18 | 939 | 91 | 1108 | 193 | 1175 |
| Non-SWOG | 1710 | 28 | 1461 | 136 | 1656 | 291 | 1771 |
| Total | 5039 | 78 | 4070 | 414 | 5041 | 857 | 5216 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| MMYEL | S2005 | WM, Prev. Untreated, I/R +/- Venetoclax | 1 | T | 20-NOV-25 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 11 |
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 10 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 9 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 7 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 7 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 5 |
| CCD | S1703 | Met Breast, STM-monitoring v Usual Care | 2 | 4 |
| PEOLC | S2408 | Panc Fistula Prevention, Lanreotide | 1 | 4 |
| BREAST | A012301 | Breast, Early Stg, Tamoxifen | 1 | 3 |
| PREV | A212102 | Blind Ref Set for Multicancer Early Detection | 1 | 3 |
| PREV | NRGCC005 | Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs | 1 | 3 |
| GU | S1802 | Pros, Stg IV, SST ± Surg/RT to Primary Tum | 1 | 3 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 3 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 3 |
| MMYEL | S2209 | MM, Newly Dx, VRd-R->R v DRd-R->R v DRD-DR->D | 1 | 3 |
| CCD | S2417CD | Colrec Surv, Follow-up w/ CTAC site | 1 | 3 |